Covid-19 roundup: Higher antibody counts seen in spaced-out vaccine intervals — study; Roche CEO compares IP waiver to East German 'experiments'
Near the outset of the UK’s vaccination campaign, the British government outlined plans to space out shots in larger intervals in order to get more people their first shot. Now, a study has come out saying the approach can drive a higher antibody response — at least in older populations.
In a study with 175 people older than 80, the antibody response was 3.5 times higher in individuals who received their second Pfizer/BioNTech shot 12 weeks after their first, compared to those who followed the typical three-week period. Antibody levels were measured about two to three weeks after the follow-up jabs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.